Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• SylvesterRJvan der MeijdenAPOosterlinckWPredicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trialsEur Urol2006493466465 discussion 475–47716442208
   PubMed Web of Science ®Google Scholar
• SolowayMSBladder cancer: Lack of progress in bladder cancer – what are the obstacles?Nat Rev Urol20131015623165404
   PubMed Web of Science ®Google Scholar
• DyrskjotLThykjaerTKruhofferMIdentifying distinct classes of bladder carcinoma using microarraysNat Genet2003331909612469123
   PubMedGoogle Scholar
• Cancer Genome Atlas ResearchNComprehensive molecular characterization of urothelial bladder carcinomaNature2014507749231532224476821
   PubMedGoogle Scholar
• KnowlesMAHurstCDMolecular biology of bladder cancer: new insights into pathogenesis and clinical diversityNat Rev Cancer2015151254125533674
   PubMed Web of Science ®Google Scholar
• CrivelliJJXylinasEKluthLARiekenMRinkMShariatSFEffect of smoking on outcomes of urothelial carcinoma: a systematic review of the literatureEur Urol201465474275423810104
   PubMed Web of Science ®Google Scholar
• YafiFAAprikianAGChinJLContemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experienceBJU Int2011108453954521166753
   PubMedGoogle Scholar
• KiemeneyLAThorlaciusSSulemPSequence variant on 8q24 confers susceptibility to urinary bladder cancerNat Genet200840111307131218794855
   PubMedGoogle Scholar
• RothmanNGarcia-ClosasMChatterjeeNA multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociNat Genet2010421197898420972438
   PubMedGoogle Scholar
• KiemeneyLASulemPBesenbacherSA sequence variant at 4p16.3 confers susceptibility to urinary bladder cancerNat Genet201042541541920348956
   PubMedGoogle Scholar
• TaioliERaimondiSGenetic susceptibility to bladder cancerLancet2005366948661061216112283
   PubMedGoogle Scholar
• Garcia-ClosasMMalatsNSilvermanDNAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesLancet2005366948664965916112301
   PubMed Web of Science ®Google Scholar
• KimPHChaEKSfakianosJPGenomic predictors of survival in patients with high-grade urothelial carcinoma of the bladderEur Urol201567219820125092538
   PubMed Web of Science ®Google Scholar
• ZengHZhengRGuoYCancer survival in China, 2003–2005: a population-based studyInt J Cancer201513681921193025242378
   PubMed Web of Science ®Google Scholar
• AndersSHuberWDifferential expression analysis for sequence count dataGenome Biol20101110R10620979621
   PubMed Web of Science ®Google Scholar
• SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Nat Acad Sci U S A2005102431554515550
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• Warde-FarleyDDonaldsonSLComesOThe GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene functionNucleic Acids Res201038Web Server issueW214W22020576703
   PubMed Web of Science ®Google Scholar
• SzklarczykDFranceschiniAWyderSSTRING v10: protein-protein interaction networks, integrated over the tree of lifeNucleic Acids Res201543Database issueD447D45225352553
   PubMed Web of Science ®Google Scholar
• BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ Royal Stat Soc Series B Statist Methodol1995571289300
   Web of Science ®Google Scholar
• ReinerAYekutieliDBenjaminiYIdentifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics200319336837512584122
   PubMed Web of Science ®Google Scholar
• BenjaminiYDraiDElmerGKafkafiNGolaniIControlling the false discovery rate in behavior genetics researchBehav Brain Res20011251–227928411682119
   PubMed Web of Science ®Google Scholar
• MhawechPGrelozVOppikoferCSzalay-QuinodozIHerrmannFExpression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progressionCancer2004100112367237515160340
   PubMed Web of Science ®Google Scholar
• SantosLLAmaroTPereiraSAExpression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladderEur J Surg Oncol2003291748012559081
   PubMed Web of Science ®Google Scholar
• YurakhAORamosDCalabuig-FarinasSMolecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladderEur Urol2006503506515 discussion 51516624482
   PubMed Web of Science ®Google Scholar
• ErillNColomerAVerduMGenetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progressionDiagn Mol Pathol200413421722315538112
   PubMedGoogle Scholar
• GeorgeBDatarRHWuLp53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancerJ Clin Oncol200725345352535818048815
   PubMed Web of Science ®Google Scholar
• SymingtonLSInitiation and completion of spontaneous mitotic recombination occur in different cell cycle phasesProc Nat Acad Sci U S A20101071880458046
   PubMedGoogle Scholar
• DayaniYSimchenGLichtenMMeiotic recombination intermediates are resolved with minimal crossover formation during return-to-growth, an analogue of the mitotic cell cyclePLoS Genet201175e100208321637791
   PubMedGoogle Scholar
• ZhengGYuHRegulation of sister chromatid cohesion during the mitotic cell cycleSci China Life Sci201558111089109826511516
   PubMed Web of Science ®Google Scholar
• GuoGSunXChenCWhole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregationNat Genet201345121459146324121792
   PubMed Web of Science ®Google Scholar
• LiDQNairSSOhshiroKMORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage responseCell Rep2012261657166923260667
   PubMed Web of Science ®Google Scholar
• WuYWangLJiangWToehold-mediated strand displacement reaction-dependent fluorescent strategy for sensitive detection of uracil-DNA glycosylase activityBiosens Bioelectron201789Pt 298498827825529
   PubMedGoogle Scholar
• BertzSAbeeCSchwarz-FurlanSIncreased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancerVirchows Arch2014465668769525326864
   PubMed Web of Science ®Google Scholar
• MiyataYKandaSOhbaKLymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -DClin Cancer Res2006123 Pt 180080616467091
   PubMed Web of Science ®Google Scholar
• AgrawalUMishraAKSalgiaPVermaSMohantyNKSaxenaSRole of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancerPathol Oncol Res20111719110120571940
   PubMedGoogle Scholar
• ShariatSFYoussefRFGuptaAAssociation of angiogenesis related markers with bladder cancer outcomes and other molecular markersJ Urol201018351744175020299037
   PubMed Web of Science ®Google Scholar
• Martin-DoyleWKwiatkowskiDJMolecular biology of bladder cancerHematol Oncol Clin North Am2015292191203vii25836928
   PubMed Web of Science ®Google Scholar
• RebouissouSBernard-PierrotIde ReyniesAEGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotypeSci Transl Med20146244244ra91
   PubMed Web of Science ®Google Scholar
• KaramJALotanYKarakiewiczPIUse of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomyLancet Oncol20078212813617267327
   PubMedGoogle Scholar
• KaramitopoulouERentschCAMarkwalderRVallanCThalmannGNBrunnerTPrognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimensPathology2010421374220025478
   PubMed Web of Science ®Google Scholar
• DuXOuXSongTAdenosine A2B receptor stimulates angiogenesis by inducing VEGF and eNOS in human microvascular endothelial cellsExp Biol Med20152401114721479
   Google Scholar
• ZhangPXuXHuXDDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesisPLoS One2013811e7944424260221
   PubMedGoogle Scholar
• YangCLiXWangYZhaoLChenWLong non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cellsGene2012496181622285928
   PubMed Web of Science ®Google Scholar
• LiCFWuWJWuWRThe cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinomaOncotarget20156119220923925940704
   PubMedGoogle Scholar
• ShetaEAHardingMAConawayMRTheodorescuDFocal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factorJ Nat Cancer Inst200092131065107310880549
   PubMedGoogle Scholar
• Chrzanowska-WodnickaMKrausAEGaleDWhiteGC2ndVansluysJDefective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient miceBlood200811152647265617993608
   PubMed Web of Science ®Google Scholar
• YanJLiFIngramDAQuilliamLARap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functionsMol Cell Biol200828185803581018625726
   PubMed Web of Science ®Google Scholar
• CarmonaGGottigSOrlandiARole of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesisBlood2009113248849718805968
   PubMedGoogle Scholar
• LakshmikanthanSSobczakMChunCRap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin alphavbeta(3)Blood201111872015202621636859
   PubMedGoogle Scholar
• SunYWuCMaJToll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signalingExp Cell Res2016347227428227426724
   PubMed Web of Science ®Google Scholar
• YangLXiaoMLiXTangYWangYLArginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathwayInt J Mol Med201637373474226847718
   PubMedGoogle Scholar
• KumarBSinclairJKhandrikaLKoulSWilsonSKoulHKDifferential effects of MAPKs signaling on the growth of invasive bladder cancer cellsInt J Oncol20093461557156419424573
   PubMedGoogle Scholar
• KumarBKoulSPetersenJp38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activityCancer Res201070283284120068172
   PubMed Web of Science ®Google Scholar
• CalderaroJRebouissouSde KoningLPI3K/AKT pathway activation in bladder carcinogenesisInt J Cancer201413481776178424122582
   PubMed Web of Science ®Google Scholar
• YugeKKikuchiEHagiwaraMNicotine induces tumor growth and chemoresistance through activation of the PI3K/Akt/mTOR pathway in bladder cancerMol Cancer Ther20151492112212026184482
   PubMed Web of Science ®Google Scholar
• SunCHChangYHPanCCActivation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladderHistopathology20115871054106321707707
   PubMed Web of Science ®Google Scholar
• BuJBuXLiuBChenFChenPIncreased expression of tissue/salivary transgelin mRNA predicts poor prognosis in patients with Oral Squamous Cell Carcinoma (OSCC)Med Sci Monit2015212275228126242444
   PubMed Web of Science ®Google Scholar
• WuXDongLZhangRYingKShenHTransgelin overexpression in lung adenocarcinoma is associated with tumor progressionInt J Mol Med201434258559124938684
   PubMedGoogle Scholar
• ZhouLZhangRZhangLUpregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancerCancer Sci2013104442343023331552
   PubMedGoogle Scholar
• LeeHWParkYMLeeSJAlpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinomaClin Cancer Res201319215879588923995859
   PubMedGoogle Scholar
• LeeMSLeeJKimJHOverexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancerOncotarget2015637403704038426430961
   PubMedGoogle Scholar
• SundararajanVGengenbacherNStemmlerMPKleemannJABrabletzTBrabletzSThe ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5Oncotarget2015629270832709626334100
   PubMedGoogle Scholar
• CuiWJLiuYZhouXLWangFZZhangXDYeLHMyosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathwayActa Pharmacol Sin201031672573220453870
   PubMedGoogle Scholar
• ZhouXLiuYYouJZhangHZhangXYeLMyosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2Cancer Lett2008270231232718710790
   PubMedGoogle Scholar
• VarisliLIdentification of new genes downregulated in prostate cancer and investigation of their effects on prognosisGenet Test Mol Biomarkers201317756256623621580
   PubMedGoogle Scholar
• AlhopuroPPhichithDTuupanenSUnregulated smooth-muscle myosin in human intestinal neoplasiaProc Nat Acad Sci U S A20081051455135518
   PubMedGoogle Scholar
• LiuPTarleSAHajraAFusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemiaScience19932615124104110448351518
   PubMed Web of Science ®Google Scholar
• MaguireJSantoroTJensenPSiebenlistUYewdellJKellyKGem: an induced, immediate early protein belonging to the Ras familyScience199426551692412447912851
   PubMed Web of Science ®Google Scholar
• SmithSCTheodorescuDThe Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic targetUrol Oncol2009271424719111797
   PubMedGoogle Scholar
• ShenYJKongZLWanFNDownregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancerCancer Sci2014105670471224684735
   PubMed Web of Science ®Google Scholar
• AntunesAANesrallahLJDall’OglioMFThe role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomyInt Braz J Urol2007333339345 discussion 34617626650
   PubMedGoogle Scholar
• LotanYBagrodiaAPassoniNProspective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomyEur Urol201364346547123571005
   PubMedGoogle Scholar
• KamatAMHahnNMEfstathiouJABladder cancerLancet2016388100612796281027345655
   PubMed Web of Science ®Google Scholar